Theophylline Anhydrous
Theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis.
United States
$4
per month
India
$1
per month
You save
−78%save $3/mo · 78% cheaper
176.3K US scripts/yr$534.1K potential annual savings$687.4K US spend/yr
Drag to rotate · 3D structureC7H8N4O2
SMILES: CN1C2=C(C(=O)N(C1=O)C)NC=N2
Compare the price
US price$4per month
India price$1per month
You save$378% less
Based on 30 units per month. US $0.13 vs India $0.03 per unit.
Total over 1 periodSave $3$4 → $1
The bigger picture
Theophylline Anhydrous is filled about 176.3K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$687.4K
If sourced from India
$153.3K
Potential annual savings
$534.1K
−78%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.